Lv2
104 积分 2024-02-28 加入
Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins
2天前
已完结
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
15天前
已完结
Phosphorus oxychloride as an efficient coupling reagent for the synthesis of esters, amides and peptides under mild conditions
21天前
已完结
Humanβ-Glucuronidase: Structure, Function, and Application in Enzyme Replacement Therapy
25天前
已完结
Highly Potent and Selective Nonsteroidal Dual Inhibitors of CYP17/CYP11B2 for the Treatment of Prostate Cancer To Reduce Risks of Cardiovascular Diseases
27天前
已完结
Tactics to Avoid Inhibition of Cytochrome P450s
28天前
已完结
An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases
1个月前
已完结
The Medicinal Chemist's Guide to Solving ADMET Challenges
1个月前
已完结
Comparative Study of Click Handle Stability in Common Ligation Conditions
1个月前
已完结
A patent review of von Hippel-Lindau (vhl)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present)
1个月前
已完结
How does equity restriction affect innovation quality? Evidence from listed manufacturing companies in China
皖公网安备34019202002308
